|
US4210478A
(en)
*
|
1973-05-08 |
1980-07-01 |
International Paper Company |
Method of making a catheter
|
|
US3959429A
(en)
*
|
1975-02-03 |
1976-05-25 |
International Paper Company |
Method of making a retention catheter and molding a tip thereon
|
|
US3985601A
(en)
*
|
1975-05-05 |
1976-10-12 |
Quantum, Inc. |
Method for producing a balloon type catheter having a smooth continuous outer surface
|
|
US4361152A
(en)
*
|
1975-05-27 |
1982-11-30 |
The Kendall Company |
Catheter
|
|
US4055187A
(en)
*
|
1976-08-05 |
1977-10-25 |
The Kendall Company |
Catheter with improved balloon assembly
|
|
US4188954A
(en)
*
|
1976-08-05 |
1980-02-19 |
The Kendall Company |
Catheter with improved balloon assembly
|
|
US4082114A
(en)
*
|
1977-01-28 |
1978-04-04 |
The Trane Company |
Valve assembly for use in an air distribution system
|
|
FR2386406A1
(fr)
*
|
1977-04-08 |
1978-11-03 |
Technological Supply |
Procede pour la fabrication d'un catheter a ballonnet
|
|
US4168710A
(en)
*
|
1977-08-10 |
1979-09-25 |
The Kendall Company |
Balloon cuff and catheter assembly
|
|
US4143651A
(en)
*
|
1977-11-03 |
1979-03-13 |
The Kendall Company |
Catheter
|
|
US4222384A
(en)
*
|
1977-11-09 |
1980-09-16 |
Biomedical Engineering Associates, Inc. |
Catheter
|
|
JPS552348U
(OSRAM)
*
|
1978-06-21 |
1980-01-09 |
|
|
|
US4284459A
(en)
*
|
1978-07-03 |
1981-08-18 |
The Kendall Company |
Method for making a molded catheter
|
|
DE2837813C3
(de)
*
|
1978-08-30 |
1981-08-20 |
Willy Rüsch GmbH & Co KG, 7053 Kernen |
Verfahren zum Herstellen eines medizinischen Tubus oder Katheters
|
|
US4251305A
(en)
*
|
1978-11-01 |
1981-02-17 |
Baxter Travenol Laboratories, Inc. |
Method of radiant heat sealing of a balloon onto a catheter employing tinted shrink tubing
|
|
JPS56152655A
(en)
*
|
1980-04-28 |
1981-11-26 |
Terumo Corp |
Balloon catheter with backward flow preventing valve
|
|
US4445891A
(en)
*
|
1980-05-05 |
1984-05-01 |
The Kendall Company |
Catheter
|
|
US4445890A
(en)
*
|
1980-05-05 |
1984-05-01 |
The Kendall Company |
Catheter
|
|
US4447228A
(en)
*
|
1980-05-05 |
1984-05-08 |
The Kendall Company |
Catheter
|
|
FR2513566A1
(fr)
*
|
1981-09-29 |
1983-04-01 |
Matburn Holdings Ltd |
Procede pour fixer ensemble les matieres plastiques et le caoutchouc
|
|
FR2521014B1
(fr)
*
|
1982-02-05 |
1988-06-03 |
Matburn Holdings Ltd |
Instrument chirurgical tubulaire, notamment catheter de thrombectomie
|
|
DE3438131C2
(de)
*
|
1984-10-18 |
1986-08-21 |
Werner Dr.med. 4330 Mülheim Schubert |
Vorrichtung zur Beseitigung von Konkrementen
|
|
US4787892A
(en)
*
|
1984-12-18 |
1988-11-29 |
The Kendall Company |
Nephrostomy catheter with formed tip
|
|
US4636272A
(en)
*
|
1985-02-19 |
1987-01-13 |
Cordis Corporation |
Process for thermally bonding plastic tubes
|
|
US4782834A
(en)
*
|
1987-01-06 |
1988-11-08 |
Advanced Cardiovascular Systems, Inc. |
Dual lumen dilatation catheter and method of manufacturing the same
|
|
US4861337A
(en)
*
|
1988-03-02 |
1989-08-29 |
Sherwood Medical Company |
Collapsible urethral catheter
|
|
US5095915A
(en)
*
|
1990-03-19 |
1992-03-17 |
Target Therapeutics |
Guidewire with flexible distal tip
|
|
JP2502174B2
(ja)
*
|
1990-08-07 |
1996-05-29 |
富士システムズ株式会社 |
バル―ンカテ―テルの製造方法
|
|
US5257451A
(en)
*
|
1991-11-08 |
1993-11-02 |
Ep Technologies, Inc. |
Method of making durable sleeve for enclosing a bendable electrode tip assembly
|
|
US5460608A
(en)
*
|
1994-01-25 |
1995-10-24 |
Scimed Life Systems, Inc. |
Kink free catheter
|
|
SE9404486D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Catheter
|
|
US5527281A
(en)
*
|
1995-07-27 |
1996-06-18 |
Haas; Joseph A. |
Substitute tip for urethral catheter
|
|
SE9600276D0
(sv)
|
1996-01-25 |
1996-01-25 |
Astra Ab |
A wetting device for wetting a hydrophilic catheter and a urine collection bag incorporating said device
|
|
US5965532A
(en)
*
|
1996-06-28 |
1999-10-12 |
Trustees Of Tufts College |
Multivalent compounds for crosslinking receptors and uses thereof
|
|
AU7100898A
(en)
|
1997-04-02 |
1998-10-22 |
Brigham And Women's Hospital |
Means of ascertaining an individual's risk profile for atherosclerotic disease
|
|
DE69938784D1
(de)
|
1998-07-15 |
2008-07-03 |
Brigham & Womens Hospital |
Polysaccharid-impfstoff gegen staphylokokken infektionen
|
|
US6368301B1
(en)
*
|
1999-12-21 |
2002-04-09 |
Advanced Cardiovascular Systems, Inc. |
Catheter having a soft distal tip
|
|
WO2001066772A2
(en)
|
2000-03-08 |
2001-09-13 |
Massachusetts Institute Of Technology |
Heparinase iii and uses thereof
|
|
CA2404858A1
(en)
*
|
2000-04-12 |
2001-10-25 |
Minerva Biotechnologies Corporation |
Treatment of neurodegenerative disease
|
|
KR100434720B1
(ko)
*
|
2001-01-03 |
2004-06-07 |
이근호 |
발룬 카테테르의 제조방법
|
|
US6692461B2
(en)
|
2001-08-07 |
2004-02-17 |
Advanced Cardiovascular Systems, Inc. |
Catheter tip
|
|
US6918920B1
(en)
*
|
2001-11-01 |
2005-07-19 |
Advanced Cardiovascular Systems, Inc. |
Catheter having an improved distal tip
|
|
WO2003078960A2
(en)
|
2002-03-11 |
2003-09-25 |
Momenta Pharmaceuticals, Inc. |
Analysis of sulfated polysaccharides
|
|
WO2003078448A1
(en)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation of protein methylation and phosphoprotein phosphate
|
|
US7344505B2
(en)
*
|
2002-10-15 |
2008-03-18 |
Transoma Medical, Inc. |
Barriers and methods for pressure measurement catheters
|
|
EP1897548B2
(en)
|
2003-02-28 |
2024-05-22 |
The Johns Hopkins University |
T cell regulation
|
|
WO2005019819A1
(en)
|
2003-08-20 |
2005-03-03 |
Biosite, Inc. |
Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
|
|
CA2534816A1
(en)
|
2003-06-12 |
2004-12-23 |
Evan Newell |
Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
|
|
US7655000B2
(en)
*
|
2003-09-26 |
2010-02-02 |
Tyco Healthcare Group Lp |
Urology catheter
|
|
US7972350B2
(en)
*
|
2004-01-29 |
2011-07-05 |
Boston Scientific Scimed, Inc. |
Catheter tip
|
|
EP1773766B1
(en)
|
2004-07-15 |
2014-04-02 |
Tetralogic Pharmaceuticals Corporation |
Iap binding compounds
|
|
JP5070052B2
(ja)
|
2004-08-17 |
2012-11-07 |
ザ・ジョンズ・ホプキンス・ユニバーシティ |
Ｐｄｅ５阻害剤組成物及び心臓疾患を治療する方法
|
|
US7893034B2
(en)
|
2004-09-02 |
2011-02-22 |
Yale University |
Regulation of oncogenes by microRNAs
|
|
US20080138847A1
(en)
*
|
2004-09-23 |
2008-06-12 |
Yigong Shi |
Bcl-2 family member and BH-3 only proteins for use in development of peptidomimetics
|
|
WO2006042192A2
(en)
|
2004-10-06 |
2006-04-20 |
The Brigham And Womens's Hospital, Inc. |
Relevance of achieved levels of markers of systemic inflammation following treatment
|
|
WO2006052940A2
(en)
*
|
2004-11-05 |
2006-05-18 |
Asthmatx, Inc. |
Medical device with procedure improvement features
|
|
US8221804B2
(en)
|
2005-02-03 |
2012-07-17 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
US8841259B2
(en)
*
|
2005-02-24 |
2014-09-23 |
Joslin Diabetes Center |
Compositions and methods for treating vascular permeability
|
|
AU2006216450C1
(en)
|
2005-02-25 |
2013-01-10 |
Medivir Ab |
Dimeric IAP inhibitors
|
|
US8354384B2
(en)
*
|
2005-06-23 |
2013-01-15 |
Yale University |
Anti-aging micrornas
|
|
AU2006270066A1
(en)
|
2005-07-19 |
2007-01-25 |
University Of Tennessee Research Foundation |
LPA2 receptor agonist inhibitors of CFTR
|
|
EP2374451A3
(en)
|
2005-07-27 |
2012-01-25 |
University of Florida Research Foundation, Inc. |
Histone deacetylase inhibitors (HDAC) that correct protein misfolding and uses thereof
|
|
WO2007021825A2
(en)
*
|
2005-08-09 |
2007-02-22 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
|
US20100256046A1
(en)
*
|
2009-04-03 |
2010-10-07 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
|
US20080021198A1
(en)
*
|
2005-10-12 |
2008-01-24 |
Yigong Shi |
Modulators of protein phosphatase 2A and PP2A methyl esterase
|
|
US8658608B2
(en)
*
|
2005-11-23 |
2014-02-25 |
Yale University |
Modified triple-helix forming oligonucleotides for targeted mutagenesis
|
|
CA2631731A1
(en)
*
|
2005-12-01 |
2007-06-07 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Compounds and methods for inhibiting apoptosis
|
|
WO2008014240A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
AU2007276760B2
(en)
|
2006-07-24 |
2012-01-19 |
Tetralogic Pharmaceuticals Corporation |
Dimeric IAP antagonists
|
|
US20100143499A1
(en)
*
|
2006-07-24 |
2010-06-10 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
US20100056495A1
(en)
*
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
EP2049524A2
(en)
*
|
2006-07-24 |
2009-04-22 |
Tetralogic Pharmaceuticals Corporation |
Iap inhibitors
|
|
US20080153773A1
(en)
*
|
2006-08-08 |
2008-06-26 |
Yigong Shi |
Modulators of phosphotyrosyl phosphatase activator
|
|
US20100092480A1
(en)
*
|
2006-10-13 |
2010-04-15 |
The Trustees Of The University Of Princeton |
Modulators of protein phosphatase 2a
|
|
US7645616B2
(en)
*
|
2006-10-20 |
2010-01-12 |
The University Of Hong Kong |
Use of lipocalin-2 as a diagnostic marker and therapeutic target
|
|
JP2010515434A
(ja)
|
2007-01-05 |
2010-05-13 |
マサチューセッツ インスティテュート オブ テクノロジー |
Ｆｌａｖｏｂａｃｔｅｒｉｕｍｈｅｐａｒｉｎｕｍ由来のスルファターゼを使用する組成物および方法
|
|
JP2010515464A
(ja)
*
|
2007-01-11 |
2010-05-13 |
イエール・ユニバーシテイ |
Ｈｉｖ細胞表面受容体の標的化不活性化のための組成物および方法
|
|
US20100119474A1
(en)
*
|
2007-03-06 |
2010-05-13 |
Cornell University |
Chronic obstructive pulmonary disease susceptibility and related compositions and methods
|
|
US20100111943A1
(en)
*
|
2007-03-22 |
2010-05-06 |
Medical College Of Georgia Research Institute, Inc |
Compositions and methods for inhibiting cancer metastasis
|
|
WO2008122039A2
(en)
*
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
US9139876B1
(en)
|
2007-05-03 |
2015-09-22 |
Momenta Pharmacueticals, Inc. |
Method of analyzing a preparation of a low molecular weight heparin
|
|
AU2008262252B2
(en)
|
2007-06-08 |
2013-09-12 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells
|
|
US20090274682A1
(en)
*
|
2008-02-05 |
2009-11-05 |
The Trustees Of Princeton University |
Demethylation and inactivation of protein phosphatase 2a
|
|
WO2009108745A1
(en)
*
|
2008-02-26 |
2009-09-03 |
The Trustees Of Princeton University |
Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation
|
|
WO2009137660A2
(en)
*
|
2008-05-07 |
2009-11-12 |
Abraxis Bioscience, Llc |
Enhancement of drug therapy by mirna
|
|
US20100146875A1
(en)
*
|
2008-05-30 |
2010-06-17 |
John Redding |
Support post structure
|
|
WO2010017103A2
(en)
*
|
2008-08-04 |
2010-02-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
Fully human anti-human nkg2d monoclonal antibodies
|
|
US8399683B2
(en)
|
2008-09-17 |
2013-03-19 |
Tetralogic Pharmaceuticals |
IAP inhibitors
|
|
EP2331103A1
(en)
*
|
2008-09-22 |
2011-06-15 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Nuclear factor kappa b pathway inhibitor composition and use of same
|
|
WO2010075417A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Survivin specific t cell receptor for treating cancer
|
|
WO2010075303A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same
|
|
US8309356B2
(en)
*
|
2009-04-01 |
2012-11-13 |
Yale University |
Pseudocomplementary oligonucleotides for targeted gene therapy
|
|
WO2010124188A1
(en)
|
2009-04-23 |
2010-10-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-human ror1 antibodies
|
|
US8686016B2
(en)
|
2009-04-30 |
2014-04-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Schweinfurthins and uses thereof
|
|
WO2010132532A1
(en)
|
2009-05-15 |
2010-11-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
B cell surface reactive antibodies
|
|
IN2012DN00352A
(OSRAM)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8283372B2
(en)
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
|
US20120269765A1
(en)
|
2009-07-24 |
2012-10-25 |
Garcia K Christopher |
Cytokine compositions and methods of use thereof
|
|
EP2287304A1
(en)
|
2009-08-17 |
2011-02-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel treatment of patients after stent implantation or balloon dilatation and novel drug eluting stents
|
|
US8465743B2
(en)
|
2009-10-01 |
2013-06-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
|
|
ES2817779T3
(es)
*
|
2010-01-19 |
2021-04-08 |
Momenta Pharmaceuticals Inc |
Evaluación de preparaciones de heparina
|
|
WO2011133802A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
|
WO2011133803A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
|
EP2595613B1
(en)
|
2010-07-22 |
2019-01-09 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Compounds for use in a method of preventing or treating viral infection
|
|
EP2646469B1
(en)
|
2010-12-01 |
2017-11-01 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Chimeric rabbit/human ror1 antibodies
|
|
EP3178932A1
(en)
|
2011-02-03 |
2017-06-14 |
Mirna Therapeutics, Inc. |
Synthetic mimics of mir-34
|
|
CN105969773A
(zh)
|
2011-02-03 |
2016-09-28 |
米尔纳医疗股份有限公司 |
Mir-124的合成模拟物
|
|
WO2012115952A1
(en)
|
2011-02-21 |
2012-08-30 |
Momenta Pharmaceuticals, Inc. |
Evaluating heparin preparations
|
|
US9296818B2
(en)
|
2011-03-14 |
2016-03-29 |
Marene Inga-Britt Landstrom |
Cleavage inhibitors of transforming growth factor beta type I receptor and uses thereof in cancer therapy
|
|
PT3459560T
(pt)
|
2011-04-08 |
2021-05-24 |
Us Health |
Recetores de antigénio quimérico variante iii de recetor de fator de crescimento antiepidérmico e utilização dos mesmos para o tratamento de cancro
|
|
BR112013027057A2
(pt)
|
2011-04-21 |
2020-08-11 |
Trustees Of Tufts College |
composições e métodos para a estabilização de agentes ativos
|
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
EP3081937B1
(en)
|
2011-07-18 |
2019-11-13 |
President and Fellows of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
|
EP2739734A1
(en)
|
2011-08-03 |
2014-06-11 |
The Charlotte-Mecklenburg Hospital Authority d/b/a Carolina Healthcare System |
Treatment of fibrosis using microrna-19b
|
|
US9499464B2
(en)
|
2011-10-19 |
2016-11-22 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
RU2644243C2
(ru)
|
2011-10-20 |
2018-02-08 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы к cd22
|
|
EP2785346A4
(en)
|
2011-11-30 |
2015-04-29 |
Bikam Pharmaceuticals Inc |
OPSINBINDING LIGANDS, COMPOSITIONS THEREOF, AND METHOD OF USE THEREOF
|
|
CA2862746A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
CA2868121C
(en)
|
2012-03-23 |
2021-06-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin chimeric antigen receptors
|
|
CA2871490C
(en)
|
2012-04-27 |
2022-10-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of cpg oligonucleotides co-formulated with an antibiotic to accelerate wound healing
|
|
EP3505537A1
(en)
|
2012-05-07 |
2019-07-03 |
Trustees of Dartmouth College |
Anti-b7-h6 antibody, fusion proteins, and methods of using the same
|
|
JP2015526471A
(ja)
|
2012-08-21 |
2015-09-10 |
ジェネシス リサーチ インスティチュート |
アントラサイクリン誘発性心毒性を治療または予防するための組成物および方法
|
|
RU2658485C2
(ru)
|
2012-10-24 |
2018-06-21 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы м971
|
|
WO2014093711A1
(en)
|
2012-12-12 |
2014-06-19 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating hepatic fibrosis and associated diseases by regulating rev-erb activity
|
|
WO2014093726A1
(en)
|
2012-12-12 |
2014-06-19 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating portal hypertension
|
|
WO2014151840A1
(en)
|
2013-03-14 |
2014-09-25 |
Children's Medical Center Corporation |
Use of cd36 to identify cancer subjects for treatment
|
|
US11376329B2
(en)
|
2013-03-15 |
2022-07-05 |
Trustees Of Tufts College |
Low molecular weight silk compositions and stabilizing silk compositions
|
|
KR102457668B1
(ko)
|
2013-03-15 |
2022-10-21 |
트러스티즈 오브 터프츠 칼리지 |
저분자량 실크 조성물 및 안정화 실크 조성물
|
|
WO2014160627A1
(en)
|
2013-03-25 |
2014-10-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-cd276 polypeptides, proteins, and chimeric antigen receptors
|
|
JP2016522165A
(ja)
|
2013-04-04 |
2016-07-28 |
イエオ−イスティトゥート・エウロペオ・ディ・オンコロジア・エッセ・エッレ・エッレ |
胸腺間質性リンパ球新生因子フラグメント及びその使用
|
|
WO2014182635A1
(en)
|
2013-05-08 |
2014-11-13 |
Baldwin Megan E |
Biomarkers for age-related macular degeneration (amd)
|
|
WO2014205516A1
(en)
|
2013-06-25 |
2014-12-31 |
The Walter And Eliza Hall Institute Of Medical Research |
Method of treating intracellular infection
|
|
WO2015006543A1
(en)
|
2013-07-10 |
2015-01-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method for predicting and detecting tumor metastasis in kidney cancer
|
|
CN105828833A
(zh)
|
2013-10-21 |
2016-08-03 |
萨克生物研究学院 |
突变的成纤维细胞生长因子（fgf）1及使用方法
|
|
RU2701346C1
(ru)
|
2013-12-06 |
2019-09-25 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы, специфичные в отношении рецептора тимусного стромального лимфопоэтина, и способы их применения
|
|
US10513546B2
(en)
|
2013-12-18 |
2019-12-24 |
President And Fellows Of Harvard College |
CRP capture/detection of gram positive bacteria
|
|
JP6727129B2
(ja)
|
2014-03-26 |
2020-07-22 |
ザ チルドレンズ メディカル センター コーポレーション |
環状プロサポシンペプチドおよびその使用
|
|
US10272019B2
(en)
|
2014-05-09 |
2019-04-30 |
Yale University |
Topical formulation of hyperbranched polyglycerol-coated particles thereof
|
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
|
ES2875057T3
(es)
|
2014-09-17 |
2021-11-08 |
Us Health |
Anticuerpos anti-CD276 (B7H3)
|
|
WO2016079527A1
(en)
|
2014-11-19 |
2016-05-26 |
Tetralogic Birinapant Uk Ltd |
Combination therapy
|
|
WO2016097773A1
(en)
|
2014-12-19 |
2016-06-23 |
Children's Cancer Institute |
Therapeutic iap antagonists for treating proliferative disorders
|
|
WO2016154585A1
(en)
|
2015-03-26 |
2016-09-29 |
Charles Sentman |
Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
|
|
BR112017026209A2
(pt)
|
2015-06-05 |
2018-11-27 |
Ibio, Inc. |
fragmentos e variantes de endostatinas para uso no tratamento de fibrose
|
|
EP3109257B1
(en)
|
2015-06-26 |
2021-01-06 |
Prindex S.r.l. |
Diagnosis and therapy of multiple sclerosis
|
|
WO2017004142A1
(en)
|
2015-06-29 |
2017-01-05 |
Children's Medical Center Corporation |
Treatment for myopathy
|
|
EP3763378A1
(en)
|
2015-08-06 |
2021-01-13 |
President and Fellows of Harvard College |
Improved microbe-binding molecules and uses thereof
|
|
UA125718C2
(uk)
|
2016-01-20 |
2022-05-25 |
Зе Скріппс Ресеарч Інстітьют |
Композиції антитіл до ror1 і пов'язані з ними способи
|
|
CA3011817A1
(en)
|
2016-01-20 |
2017-07-27 |
The Scripps Research Institute |
Ror2 antibody compositions and related methods
|
|
CA3014795A1
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
|
CN109476706A
(zh)
|
2016-02-16 |
2019-03-15 |
耶鲁大学 |
用于促进靶向基因编辑的组合物及其使用方法
|
|
AU2017253935B2
(en)
|
2016-04-19 |
2021-07-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of gram negative species to treat atopic dermatitis
|
|
US10293005B2
(en)
|
2016-04-19 |
2019-05-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of gram negative species to treat atopic dermatitis
|
|
US20190391152A1
(en)
|
2016-05-16 |
2019-12-26 |
Checkmab S.R.L. |
Markers selectively deregulated in tumor-infiltrating regulatory t cells
|
|
EP4413999A3
(en)
|
2016-05-27 |
2024-08-28 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Flt3-specific chimeric antigen receptors and methods using same
|
|
WO2017207623A1
(en)
|
2016-05-31 |
2017-12-07 |
Université de Lausanne |
Mirna as biomarkers and regulators of cancer stem cells
|
|
US20190322643A1
(en)
|
2016-06-29 |
2019-10-24 |
Georgia State University Research Foundation, Inc. |
Histone deacetylase and histone methyltransferase inhibitors and methods of making and use of the same
|
|
US20190201414A1
(en)
|
2016-07-01 |
2019-07-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv |
Inhibitor of heme degradation for use to improve antibiotic treatment of mycobacterium tuberculosis infection
|
|
US11260132B2
(en)
|
2017-03-16 |
2022-03-01 |
Children's Medical Center Corporation |
Engineered liposomes as cancer-targeted therapeutics
|
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
|
WO2018200722A1
(en)
|
2017-04-25 |
2018-11-01 |
Prothera Biologics, Inc. |
Methods for quantifying inter-alpha inhibitor proteins
|
|
CA3099487A1
(en)
|
2017-07-20 |
2019-01-24 |
Nbe-Therapeutics Ag |
Human antibodies binding to ror2
|
|
KR102486090B1
(ko)
|
2017-08-07 |
2023-01-10 |
엔비이-테라퓨틱스 아게 |
생체 내 내성이 높은 항체 약물 결합체
|
|
WO2019154884A1
(en)
|
2018-02-07 |
2019-08-15 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for determining cancer invasiveness and patient prognosis
|
|
SG11202011188SA
(en)
|
2018-05-11 |
2020-12-30 |
Forte Subsidiary Inc |
Compositions for the treatment of skin conditions
|
|
EP3860635A4
(en)
|
2018-10-04 |
2022-07-06 |
Rutgers, The State University of New Jersey |
Methods of reducing type 2 cytokine-mediated inflammation using neuromedin peptides
|
|
WO2020081737A1
(en)
|
2018-10-16 |
2020-04-23 |
Massachusetts Institute Of Technology |
Compositions and methods for inducing intestinal stem cell regeneration
|
|
US20210340562A1
(en)
|
2018-10-19 |
2021-11-04 |
Board Of Regents, The University Of Texas System |
Engineered long interspersed element (line) transposons and methods of use
|
|
EP3677693A1
(en)
|
2019-01-03 |
2020-07-08 |
Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO |
Transpochimeric gene trancripts (tcgts) as cancer biomarkers
|
|
CN113597433B
(zh)
|
2019-01-18 |
2024-12-27 |
詹森生物科技公司 |
Gprc5d嵌合抗原受体以及表达这些受体的细胞
|
|
JP2022524289A
(ja)
|
2019-01-30 |
2022-05-02 |
ヤンセン ファーマシューティカ エヌ．ベー． |
分子サブタイプに基づいて前立腺癌を治療する方法
|
|
WO2020186187A1
(en)
|
2019-03-13 |
2020-09-17 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods for treating bladder and urethra dysfunction and disease
|
|
WO2020210719A1
(en)
|
2019-04-10 |
2020-10-15 |
Elevatebio Management, Inc. |
Flt3-specific chimeric antigen receptors and methods of using the same
|
|
CA3139032A1
(en)
|
2019-05-22 |
2020-11-26 |
Robert Alexander WESSELHOEFT |
Circular rna compositions and methods
|
|
WO2020239478A1
(en)
|
2019-05-28 |
2020-12-03 |
Pharma Mar, S.A. |
Trabectedin for treating sarcomas based on genomic markers
|
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
|
WO2020257779A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
|
JOP20220018A1
(ar)
|
2019-07-26 |
2023-01-30 |
Janssen Biotech Inc |
مستقبل المستضدات الخيمري لـ hK2 المضاد (CAR)
|
|
MX2022001049A
(es)
|
2019-07-26 |
2022-05-03 |
Janssen Biotech Inc |
Proteínas que comprenden dominios de unión al antígeno de la peptidasa 2 relacionada con la calicreína y sus usos.
|
|
US12496357B2
(en)
|
2019-07-31 |
2025-12-16 |
Yale University |
Compositions and methods for treating sickle cell disease
|
|
CN112390894A
(zh)
|
2019-08-12 |
2021-02-23 |
广东东阳光药业有限公司 |
嵌合抗原受体及其应用
|
|
CA3151344A1
(en)
|
2019-08-16 |
2021-02-25 |
Janssen Biotech, Inc. |
Therapeutic immune cells with improved function and methods for making the same
|
|
KR20220114560A
(ko)
|
2019-11-18 |
2022-08-17 |
얀센 바이오테크 인코포레이티드 |
항-cd79 키메라 항원 수용체, car-t 세포 및 이의 용도
|
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
|
EP3868396A1
(en)
|
2020-02-20 |
2021-08-25 |
Enthera S.R.L. |
Inhibitors and uses thereof
|
|
CA3169482A1
(en)
|
2020-02-26 |
2021-09-02 |
Krzysztof Palczewski |
Compositions and methods for treating misfolded protein ocular disorders
|
|
UY40280A
(es)
|
2020-03-13 |
2023-07-31 |
Janssen Biotech Inc |
Dominios de unión a antígeno que se unen a la proteina cd33 de la superficie de células mieloides
|
|
WO2021225781A2
(en)
|
2020-05-07 |
2021-11-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aberrant post-translational modifications (ptms) in methyl- and propionic acidemia and a mutant sirtuin (sirt) to metabolize ptms
|
|
JP2023527309A
(ja)
|
2020-05-19 |
2023-06-28 |
オルナ セラピューティクス インコーポレイテッド |
環状ｒｎａ組成物及び方法
|
|
JP2023537470A
(ja)
|
2020-08-03 |
2023-09-01 |
ヤンセン バイオテツク，インコーポレーテツド |
ウイルス治療における多方向バイオ輸送のための材料及び方法
|
|
CN112295084B
(zh)
*
|
2020-09-25 |
2023-03-28 |
池州市琼琚信息技术服务有限公司 |
一种热收缩膜固定胶水形状的方法
|
|
WO2022081895A1
(en)
|
2020-10-16 |
2022-04-21 |
University Of Georgia Research Foundation, Inc. |
Glycoconjugates
|
|
EP4059498A1
(en)
|
2021-03-16 |
2022-09-21 |
Centre Hospitalier Universitaire Vaudois (CHUV) |
Methods and compositions for treating conditions associated with hypermineralization
|
|
TW202304986A
(zh)
|
2021-03-24 |
2023-02-01 |
美商健生生物科技公司 |
靶向cd22及cd79b的抗體
|
|
WO2022237974A1
(en)
|
2021-05-12 |
2022-11-17 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Krab-containing zinc finger protein and cancer
|
|
CN115404240A
(zh)
|
2021-05-28 |
2022-11-29 |
上海环码生物医药有限公司 |
制备环形rna的构建体、方法及其用途
|
|
EP4352226A1
(en)
|
2021-06-07 |
2024-04-17 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
|
WO2022271955A1
(en)
|
2021-06-23 |
2022-12-29 |
Musc Foundation For Research Development |
Novel targeted shrna nanoparticles for cancer therapy
|
|
KR20240049361A
(ko)
|
2021-08-25 |
2024-04-16 |
아이바이오, 인크. |
항-cd25 항체
|
|
US20250019455A1
(en)
|
2021-09-24 |
2025-01-16 |
Pharmaceutica Nv |
Proteins comprising cd20 binding domains, and uses thereof
|
|
WO2023081526A1
(en)
|
2021-11-08 |
2023-05-11 |
Orna Therapeutics, Inc. |
Lipid nanoparticle compositions for delivering circular polynucleotides
|
|
CN120092091A
(zh)
|
2022-05-30 |
2025-06-03 |
上海环码生物医药有限公司 |
合成的环状rna组合物及其使用方法
|
|
US12297285B2
(en)
|
2022-06-24 |
2025-05-13 |
Orna Therapeutics, Inc. |
Circular RNA encoding chimeric antigen receptors targeting BCMA
|
|
WO2024094526A1
(en)
|
2022-11-02 |
2024-05-10 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
6-diazo-5-oxo-l-norleucine prodrugs
|
|
WO2024102730A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and nanoparticle compositions for delivering polynucleotides
|
|
WO2024102762A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
|
AU2023398825A1
(en)
|
2022-12-15 |
2025-06-26 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
WO2024205657A2
(en)
|
2023-03-29 |
2024-10-03 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
|
WO2024233308A2
(en)
|
2023-05-05 |
2024-11-14 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
WO2024263649A1
(en)
|
2023-06-19 |
2024-12-26 |
Yale University |
Methods and compositions for enrichment and sequencing of expansion-specific rna transcripts
|
|
WO2025007148A1
(en)
|
2023-06-30 |
2025-01-02 |
Orna Therapeutics, Inc. |
Polymer lipid nanoparticle compositions for delivering circular polynucleotides
|
|
WO2025021993A1
(en)
|
2023-07-27 |
2025-01-30 |
Omnilinx Therapeutics Ag |
Endocytic and scavenger receptor-targeting chimeric proteins and uses thereof
|
|
WO2025049690A1
(en)
|
2023-08-29 |
2025-03-06 |
Orna Therapeutics, Inc. |
Circular polyethylene glycol lipids
|
|
EP4537907A1
(en)
|
2023-10-10 |
2025-04-16 |
Enthera S.r.l. |
Cd248 inhibitors and uses thereof
|
|
WO2025117969A1
(en)
|
2023-12-01 |
2025-06-05 |
Orna Therapeutics, Inc. |
Process for manufacturing lipid nanoparticles
|
|
WO2025247961A1
(en)
|
2024-05-31 |
2025-12-04 |
Centre Hospitalier Universitaire Vaudois (C.H.U.V.) |
Lpa-lpar signaling as a therapeutic target or diagnostic tool for brain diseases
|
|
WO2025257171A1
(en)
|
2024-06-13 |
2025-12-18 |
Ideogen A.G. |
Combination therapy for treating cancer such as lymphoma
|
|
WO2025257173A1
(en)
|
2024-06-13 |
2025-12-18 |
Ideogen A.G. |
Combination therapy for treating cancer such as lymphoma
|
|
WO2025257176A1
(en)
|
2024-06-13 |
2025-12-18 |
Ideogen A.G. |
Combination therapy for treating cancer such as lymphoma
|